Clinical trial
Surgery and BCG in Treating Patients With Bladder Cancer
NCT00002990 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00002990 |
|---|---|
| Title | Surgery and BCG in Treating Patients With Bladder Cancer |
| Official title | Comparative Study of Intravesical BCG Standard Dose Long-Term Maintenance Versus BCG 1/3 Dose Long-Term Maintenance Versus BCG Standard Dose Short-Term Maintenance Versus BCG 1/3 Dose Short-Term Maintenance in Intermediate and High Risk Ta, T1 Papillary Carcinoma of the Urinary Bladder |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Biological |
| Interventions | BCG vaccine |
| Enrollment | 1,288 |
| Start date | Mar 1, 1997 |
| Primary completion | Apr 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 12, 2013 |
| Countries | Austria, Belgium, France, Greece, Israel, Italy, Netherlands, Portugal, Romania, Turkey (Türkiye), United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: